Incremental progress and measured successes
From hardened software to scientific productivity, the NCBCs have changed the landscape for biomedical computing. What will happen when their funding expires?
Finding the Master Regulators
Computation strives to make prostate cancer less menacing
Decades of steady progress in pharmacogenetics have unearthed hundreds of associations between genes and drug response. But the field has to solve some theoretical and practical issues before it can deliver on the promise of personalized drug therapy.
Experts reflect on challenges identified ten years ago.